Organogenesis Holdings, Inc. (ORGO)
1.33
-0.07
(-5.00%)
USD |
NASDAQ |
Oct 02, 16:00
1.325
0.00 (0.00%)
After-Hours: 20:00
Organogenesis Holdings EPS Diluted (Quarterly) : -0.772 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.772 |
| March 31, 2026 | -0.4394 |
| December 31, 2025 | 0.2657 |
| September 30, 2025 | 0.111 |
| June 30, 2025 | -0.0962 |
| March 31, 2025 | -0.171 |
| December 31, 2024 | 0.0581 |
| September 30, 2024 | 0.0921 |
| June 30, 2024 | -0.1286 |
| March 31, 2024 | -0.0159 |
| December 31, 2023 | -0.0043 |
| September 30, 2023 | 0.0237 |
| June 30, 2023 | 0.04 |
| March 31, 2023 | -0.0226 |
| December 31, 2022 | 0.0568 |
| September 30, 2022 | 0.0016 |
| June 30, 2022 | 0.0659 |
| March 31, 2022 | -0.0071 |
| December 31, 2021 | 0.3824 |
| September 30, 2021 | 0.094 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.1544 |
| March 31, 2021 | 0.0745 |
| December 31, 2020 | 0.1517 |
| September 30, 2020 | 0.1913 |
| June 30, 2020 | -0.0493 |
| March 31, 2020 | -0.1558 |
| December 31, 2019 | -0.045 |
| September 30, 2019 | -0.1234 |
| June 30, 2019 | -0.1064 |
| March 31, 2019 | -0.1729 |
| December 31, 2018 | -0.1203 |
| September 30, 2018 | 0.0966 |
| June 30, 2018 | -0.09 |
| March 31, 2018 | -0.11 |
| December 31, 2017 | -0.13 |
| September 30, 2017 | -0.30 |
| June 30, 2017 | -0.02 |
| March 31, 2017 | 0.02 |
| December 31, 2016 | -0.02 |
| September 30, 2016 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| cbdMD, Inc. | -0.1129 |
| Guardian Pharmacy Services, Inc. | 0.3426 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Agenus, Inc. | -0.0146 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -96.27M |
| Revenue (Quarterly) | 43.76M |
| Total Expenses (Quarterly) | 140.02M |
| Enterprise Value | 331.11M |
| Gross Profit Margin (Quarterly) | 30.84% |
| Profit Margin (Quarterly) | -220.0% |
| Earnings Yield | -62.76% |
| Normalized Earnings Yield | -58.23 |